Business · 19/04/2018
FDA Releases Draft Guidance for Quality Considerations of Metered Dose Inhalers and Dry Powder Inhalers
The FDA has released a draft guidance for industry outlining quality considerations for the development and manufacture of metered dose inhalers and dry powder inhalers, with potential applicability to nasal delivery products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →